Meridian Bioscience reported $40.87M in EBITDA for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbott ABT:US $ 3735M 316M
Accelerate Diagnostics AXDX:US -15279000 1.01M
Atrion ATRI:US 11.2M 1.6M
Becton, Dickinson and BDX:US $ 1362M 105M
Bio Rad Laboratories BIO:US $ 175.52M 38.34M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Cerus CERS:US $ -8.98M 2.83M
Meridian Bioscience VIVO:US $ 40.87M 16.12M
Myriad Genetics MYGN:US $ -1.9M 34.1M
Orasure Technologies OSUR:US $ -12.33M 6.18M
Quidel QDEL:US $ 640.48M 241.54M
Sientra SIEN:US $ -14.35M 1.84M
Staar Surgical STAA:US $ 13.12M 4.79M
Thermo Fisher Scientific TMO:US $ 3682M 304M
Utah Medical Products UTMD:US 6.92M 1.2M